A Novel Model of Care for Advanced Parkinson’s Disease and Related Disorders: Interdisciplinary Home Visits
Objective: To describe the structure and feasibility of an interdisciplinary home visit program (HVP) for homebound advanced Parkinson’s disease (PD) and related disorders. Background: As…Quality of Life in Homebound People with Advanced Parkinson’s Disease: Feasibility and Outcomes of an Interdisciplinary Home Visit Program
Objective: 1) To demonstrate the feasibility of an interdisciplinary home visit program (HVP) for advanced Parkinson’s disease (PD) providing expert, interdisciplinary care directly to homebound…Psychosocial Impact of X-Linked Dystonia Parkinsonism (XDP) of Panay
Objective: The study will determine the patient’s quality of life and their subjective psychological well-being by using the Parkinson Disease Questionnaire (PDQ) - 39 and the World Health…Suicide in Parkinson disease
Objective: This study was carried out to analyze the suicide rate in our Parkinson disease (PD) population and review the clinical profiles of patients who…Psychosocial evaluation in caregivers of patients with Parkinson’s disease: analysis of a cohort of Rio de Janeiro / Brazil
Objective: Evaluate the demographic profile, psychosocial aspects and knowledge about the disease in caregivers of patients with PD attended by a reference center in Rio…Advance care planning in advanced Parkinsonian patients in a long-term care hospital
Objective: To investigate current status of advance care planning in patients with Parkinsonian disorders Background: End-of-life sufferings of patients with Parkinson’s disease (PD) were reported…The Value of Follow Up: The Role of Social Work and Nursing Calls in an Interdisciplinary Home Visit Program for Advanced Parkinson’s Disease Patients
Objective: To describe nursing and social work cross-discipline efforts to improve patient care and adherence to treatment plans as part of an interdisciplinary home visit…The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.
Objective: To present highlights from the Patient-Focused Drug Development (PFDD) meetings held at FDA for Parkinson’s disease (PD) and Huntington’s disease (HD) to raise awareness…A national Swedish self-management program for people with Parkinson’s disease – patients and relatives view
Objective: To identify and describe experiences that people with PD and their relatives after participation in the self-management intervention NPS (National Parkinson School) find valuable for managing daily life. Background:…Management of parkinsonism in primary care.
Objective: To assess the use of inappropriate drugs among patients with parkinsonism in primary care. As secondary objectives, we planned to identify those clinical factors…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.